Form 4: Oncology Institute Director Brad Hively Sells Shares to Cover Tax Obligations
SEC Form 4
Director Brad Hively sold 18,121 shares of Oncology Institute, Inc. to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On June 17, 2024, Brad Hively, a director of Oncology Institute, Inc. (TOI), sold 18,121 shares of common stock.
- The sale was executed at a price of $0.4578 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
- Following the transaction, Hively directly owns 676,203 shares of Oncology Institute, Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The transaction is a routine sale to cover tax obligations, which is a normal part of executive compensation. It doesn't necessarily reflect a positive or negative view of the company's prospects.
Industry Context
Sales to cover tax obligations are a routine part of equity compensation and are not necessarily indicative of a negative outlook on the company.
Stakeholder Impact
- The sale of shares by a director could have a minor negative impact on shareholder sentiment, although it is likely to be minimal given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 06/17/2024 | Date of transaction: Brad Hively sold shares of Oncology Institute, Inc. |
| 06/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.